研究TAS2R16基因变异和蛋白质水平对多发性硬化症发展的潜在影响
Greta Gedvilaite1,2, Enrika Pileckaite1,2, Ignas Ramanauskas2
1Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Journal of personalized medicine
|April 27, 2024
概括
包括rs860170在内的TAS2R16中的特定基因变异以及TAS2R16血清水平升高与多发性硬化症 (MS) 风险增加有关. 这些发现突出了MS发展和个性化治疗策略的潜在生物标志物.
科学领域:
- 遗传学和分子生物学
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 多发性硬化症 (MS) 是一种复杂的自身免疫性疾病,影响中枢神经系统.
- 多发性硬化症的遗传和分子基础需要进一步阐明.
- 目前尚不清楚TAS2R16基因及其编码蛋白在MS中的作用.
研究的目的:
- 研究TAS2R16基因多态 (rs860170, rs978739, rs1357949),血清TAS2R16水平和多发性硬化症 (MS) 之间的关联.
- 识别MS风险和发病因子的潜在遗传和蛋白质生物标志物.
主要方法:
- 使用实时聚合酶链反应 (RT-PCR) 进行TAS2R16单核酸多态 (SNPs) 的基因定型.
- 在218名多发性硬化患者和265名健康对照中,通过ELISA量化血清TAS2R16度.
- 统计分析包括基因型,单元型和血清水平比较.
主要成果:
- 在TAS2R16 rs860170 CC基因型显著增加了MS的几率约27倍 (p=0.002),每个C等位基因提高了1.8倍 (p<0.001) 的几率.
- 这种C-C-A单元型 (rs860170,rs978739,rs1357949) 与患MS的风险增加了12倍 (p=0.02).
- 与对照组相比,在MS患者中观察到血清TAS2R16水平升高 (p=0.014).
结论:
- 特定的TAS2R16基因变异 (rs860170,rs978739,rs1357949) 和血清TAS2R16水平升高与多发性硬化症风险增加有关.
- 这些发现表明TAS2R16在MS病变发生过程中可能发挥作用.
- 这项研究强调了基因和血清生物标志物的重要性,以了解多发性硬化和开发个性化医疗方法.
更多相关视频
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
1.4K
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.0K
相关概念视频
Human Genetics
564
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
564
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
